Enzo Biochem (LTS:0IHV) Total Assets : $67.51 Mil (As of Jan. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Enzo Biochem Total Assets?

Enzo Biochem's Total Assets for the quarter that ended in Jan. 2025 was $67.51 Mil.

During the past 12 months, Enzo Biochem's average Total Assets Growth Rate was -29.90% per year. During the past 3 years, the average Total Assets Growth Rate was -21.90% per year. During the past 5 years, the average Total Assets Growth Rate was -9.30% per year. During the past 10 years, the average Total Assets Growth Rate was -0.60% per year.

During the past 13 years, Enzo Biochem's highest 3-Year average Total Assets Growth Rate was 82.40%. The lowest was -21.90%. And the median was -0.20%.

Total Assets is connected with ROA %. Enzo Biochem's annualized ROA % for the quarter that ended in Jan. 2025 was -8.60%. Total Assets is also linked to Revenue through Asset Turnover. Enzo Biochem's Asset Turnover for the quarter that ended in Jan. 2025 was 0.10.

Enzo Biochem Total Assets Historical Data

The historical data trend for Enzo Biochem's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem Total Assets Chart

Enzo Biochem Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Total Assets

Get a 7-Day Free Trial

112.54

113.69

75.61

121.88

85.76

Enzo Biochem Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Total Assets	Get a 7-Day Free Trial															99.08	93.47	85.76	75.29	67.51

Enzo Biochem Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Enzo Biochem's Total Assets for the fiscal year that ended in Jul. 2024 is calculated as

Total Assets	=	Total Equity (A: Jul. 2024 )	+	Total Liabilities (A: Jul. 2024 )
	=	56.112	+	29.652
	=	85.76

Enzo Biochem's Total Assets for the quarter that ended in Jan. 2025 is calculated as

Total Assets	=	Total Equity (Q: Jan. 2025 )	+	Total Liabilities (Q: Jan. 2025 )
	=	46.616	+	20.894
	=	67.51

Enzo Biochem (LTS:0IHV) Total Assets Explanation

Total Assets is connected with ROA %.

Enzo Biochem's annualized ROA % for the quarter that ended in Jan. 2025 is

ROA %	=	Net Income (Q: Jan. 2025 )	/	( (Total Assets (Q: Oct. 2024 )	+	Total Assets (Q: Jan. 2025 ))	/ count )
	=	-6.14	/	( (75.291	+	67.51)	/ 2 )
	=	-6.14	/	71.4005
	=	-8.60 %

Note: The Net Income data used here is four times the quarterly (Jan. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Enzo Biochem's Asset Turnover for the quarter that ended in Jan. 2025 is

	Asset Turnover
=	Revenue (Q: Jan. 2025 )	/	( (Total Assets (Q: Oct. 2024 )	+	Total Assets (Q: Jan. 2025 ))	/ count )
=	7.334	/	( (75.291	+	67.51)	/ 2 )
=	7.334	/	71.4005
=	0.10

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Enzo Biochem Total Assets Related Terms

Thank you for viewing the detailed overview of Enzo Biochem's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzo Biochem Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (LTS:0IHV) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

ENZ:USA

Address

21 Executive Boulevard, Farmingdale, NY, USA, 11735

Website

https://www.enzo.com

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

Enzo Biochem Headlines

No Headlines